GlassScriptPhysician profile
Matthew Martinez
NPI 1841903721
$1,339.11
in general payments reported to CMS, 2019-2025
11 companies · $487 in 2025
The $487 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $510 · 2024: $342 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974 · Education: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.11 |
| Education | $365.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $432.08 | 2023-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $254.24 | 2023-2024 | Infuse |
| Alcon Vision LLC | $232.29 | 2023-2025 | Clareon, Precision7, Acrysof Iq Panoptix Uv Iol |
| Biotissue Holdings INC. | $168.70 | 2024 | |
| Sun Pharmaceutical Industries INC. | $72.70 | 2023-2025 | Cequa |
| Mallinckrodt Hospital Products INC. | $57.06 | 2023-2024 | Acthar |
| Thea Pharma INC. | $45.93 | 2023 | Iyuzeh |
| Lkc Technologies, INC. | $28.18 | 2025 | |
| Sight Sciences, INC. | $19.71 | 2023 | Omni Surgical System |
| Rxsight INC | $14.32 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Handpiece |
| Coopervision INC. | $13.90 | 2025 | Clariti Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.